Jeil Pharmaceutical Co.,Ltd (KRX:271980)

KRX:271980 Statistics

Total Valuation

KRX:271980 has a market cap or net worth of KRW 201.67 billion. The enterprise value is 275.63 billion.

Market Cap	201.67B
Enterprise Value	275.63B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:271980 has 14.57 million shares outstanding.

Current Share Class	14.57M
Shares Outstanding	14.57M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.15%
Owned by Institutions (%)	0.18%
Float	5.42M

Valuation Ratios

The trailing PE ratio is 39.07.

PE Ratio	39.07
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.89
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.28, with an EV/FCF ratio of -12.63.

EV / Earnings	53.39
EV / Sales	0.42
EV / EBITDA	13.28
EV / EBIT	30.63
EV / FCF	-12.63

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.41.

Current Ratio	1.26
Quick Ratio	0.82
Debt / Equity	0.41
Debt / EBITDA	4.54
Debt / FCF	-4.32
Interest Coverage	2.06

Financial Efficiency

Return on equity (ROE) is 3.55% and return on invested capital (ROIC) is 1.93%.

Return on Equity (ROE)	3.55%
Return on Assets (ROA)	1.15%
Return on Invested Capital (ROIC)	1.93%
Return on Capital Employed (ROCE)	3.70%
Revenue Per Employee	698.63M
Profits Per Employee	5.45M
Employee Count	947
Asset Turnover	1.35
Inventory Turnover	4.30

Taxes

Income Tax	-126.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.44% in the last 52 weeks. The beta is 0.84, so KRX:271980's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+0.44%
50-Day Moving Average	14,213.80
200-Day Moving Average	12,713.50
Relative Strength Index (RSI)	52.84
Average Volume (20 Days)	17,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:271980 had revenue of KRW 661.60 billion and earned 5.16 billion in profits. Earnings per share was 354.28.

Revenue	661.60B
Gross Profit	195.23B
Operating Income	9.00B
Pretax Income	7.26B
Net Income	5.16B
EBITDA	20.75B
EBIT	9.00B
Earnings Per Share (EPS)	354.28

Balance Sheet

The company has 53.44 billion in cash and 94.25 billion in debt, giving a net cash position of -40.80 billion or -2,800.32 per share.

Cash & Cash Equivalents	53.44B
Total Debt	94.25B
Net Cash	-40.80B
Net Cash Per Share	-2,800.32
Equity (Book Value)	227.22B
Book Value Per Share	13,318.10
Working Capital	61.87B

Cash Flow

In the last 12 months, operating cash flow was -15.88 billion and capital expenditures -5.94 billion, giving a free cash flow of -21.82 billion.

Operating Cash Flow	-15.88B
Capital Expenditures	-5.94B
Free Cash Flow	-21.82B
FCF Per Share	-1,497.51

Margins

Gross margin is 29.51%, with operating and profit margins of 1.36% and 0.78%.

Gross Margin	29.51%
Operating Margin	1.36%
Pretax Margin	1.10%
Profit Margin	0.78%
EBITDA Margin	3.14%
EBIT Margin	1.36%
FCF Margin	n/a

Dividends & Yields

KRX:271980 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.56%
FCF Yield	-10.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 11, 2018. It was a forward split with a ratio of 1.4.

Last Split Date	Apr 11, 2018
Split Type	Forward
Split Ratio	1.4

Scores

KRX:271980 has an Altman Z-Score of 1.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	4